CCDRD Cooperative Clinical Drug Research and Development AG, PureIMS B.V.
Sponsor type
Pharmaceutical company, Pharmaceutical company
Therapeutic area
Respiratory Tract Diseases
Decision date
14/09/2026
Enrollment target
26
Sites
Bulgaria
Condition studied
No therapeutic indication in the current bioavailability trial with healthy adult participants.
Eligibility
Age group
18-64 years
Sex
Female, Male
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.